Therefore, these results suggested that rosuvastatin and sarpogrelate were indeed involved in reducing the CD68-positive monocyte/macrophage-mediated proinflammatory activity induced by HD in ApoE-deficient mice. This evidence concerns the gene CD68 and Huntington disease.